Balance Sheet

Cash Flow Statement

Amortization Amortization Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Uxin (UXIN) Asset Writedowns and Impairment (2019 - 2024)

Uxin filings provide 3 years of Asset Writedowns and Impairment readings, the most recent being $1.4 million for Q4 2024.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to $1.4 million in Q4 2024 year-over-year; TTM through Dec 2024 was $55.3 million, a N/A change, with the full-year FY2025 number at $3.6 million, changed N/A from a year prior.
Asset Writedowns and Impairment hit $1.4 million in Q4 2024 for Uxin, up from $834344.3 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $58.4 million in Q1 2020 to a low of $834344.3 in Q2 2024.